Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial

Published:2016-12 Issue:6 Volume:138 Page:1631-1638
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Nolte Hendrik,Bernstein David I.,Nelson Harold S.,Kleine-Tebbe Jörg,Sussman Gordon L.,Seitzberg Dorthe,Rehm Dorte,Kaur Amarjot,Li Ziliang,Lu Susan

Funder

Merck & Co

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Allergen immunotherapy and tolerance;Matsuoka;Allergol Int,2013

2. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial;Durham;J Allergy Clin Immunol,2012

3. Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children;Corzo;J Investig Allergol Clin Immunol,2014

4. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites;Maloney;Ann Allergy Asthma Immunol,2016

5. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber;Nolte;J Allergy Clin Immunol,2015

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

2. The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis;Journal of Allergy and Clinical Immunology: Global;2024-08

3. Management of Allergic Rhinitis in the United Arab Emirates: Expert Consensus Recommendations on Allergen Immunotherapy;Cureus;2024-07-24

4. Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions;Allergy and Asthma Proceedings;2024-07-01

5. Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis;The Journal of Allergy and Clinical Immunology: In Practice;2024-06